title: [Valve repair surgery in infectious endocarditis].
abstract: BACKGROUND
  Valve replacement has been the treatment of choice for patients with valvular complications of infectious endocarditis (IE). However, excellent results with valve repair allowed it to become a new therapeutic alternative for these patients.
  
  
  OBJECTIVE
  To evaluate the results of valve repair in patients with valvular complications of IE.
  
  
  METHODS
  From January 1991 to December 2000, 14 patients with valvular complications of IE underwent valve repair. Mean age was 37.9 +/- 14.9.
  
  
  RESULTS
  New York Heart Association (NYHA) class was 2.8 +/- 0.9. IE was located in the aortic in 6 (42%), in the mitral valve in 4 (29%) and in both valves in 4 cases (29%). Surgical indication was hemodynamic in 50% of the cases, echocardiographic in 29% and septic in 21%. Five aortic valves were bicuspid, 3 mitral valves were myxomatous and the rest were normal. The most common septic lesions were vegetations and leaflet perforations. A total of 23 aortic and 21 mitral valve repair procedures were performed. There were no deaths. Only 1 patient had a surgical complication (renal failure and prolonged mechanical ventilation). Follow-up was 100% complete. There was not late mortality. One patient with bone marrow aplasia required reoperation for a new episode of IE 19 months later. At the end of the follow-up NYHA class was 1.3 +/- 0.6 and echocardiography showed a mild or absence of valve regurgitation in most patients.
  
  
  CONCLUSIONS
  Valve repair surgery in IE has good results, with advantages over valve replacement.
authors.affiliation: Departamento de Enfermedades Cardiovasculares, Facultad de Medicina, Pontificia Universidad Católica de Chile. rzalaque@med.puc.cl
authors.forename: Ricardo
authors.initials: R
authors.lastname: Zalaquett
authors.forename: Luis
authors.initials: L
authors.lastname: Garrido
authors.forename: Francisca
authors.initials: F
authors.lastname: Casas
authors.forename: Sergio
authors.initials: S
authors.lastname: Morán
authors.forename: Manuel J
authors.initials: MJ
authors.lastname: Irarrázaval
authors.forename: Pedro
authors.initials: P
authors.lastname: Becker
authors.forename: Sandra
authors.initials: S
authors.lastname: Braun
authors.forename: Samuel
authors.initials: S
authors.lastname: Córdova
authors.forename: Gastón
authors.initials: G
authors.lastname: Chamorro
authors.forename: Iván
authors.initials: I
authors.lastname: Godoy
authors.forename: Fernando
authors.initials: F
authors.lastname: Yáñez
authors.forename: Jaime
authors.initials: J
authors.lastname: Labarca
authors.forename: Carlos
authors.initials: C
authors.lastname: Pérez
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001021:Aortic Valve / Q000601:surgery*; D001022:Aortic Valve Insufficiency / Q000188:drug therapy / Q000601:surgery; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000601:surgery*; D005260:Female; D006349:Heart Valve Diseases / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000601:surgery
chemical_list: D000900:Anti-Bacterial Agents
vernacular_title: Cirugía valvular reparadora en endocarditis infecciosa.